Ascentage Pharma to Report 2025 Six Month Interim Results and Provide Corporate Update on August 20, 2025

Ascentage Pharma to Report 2025 Six Month Interim Results and Provide Corporate Update on August 20, 2025 GlobeNewswire August 07, 2025 ROCKVILLE, Md. and SUZHOU, China, Aug. 07, 2025 (GLOBE NEWSWIRE) — Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company“), a global biopharmaceutical company dedicated to addressing unmet medical needs […]

Stryker declares an $0.84 per share quarterly dividend

Stryker declares an $0.84 per share quarterly dividend GlobeNewswire August 07, 2025 Portage, Michigan, Aug. 07, 2025 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.84 per share payable October 31, 2025, to shareholders of record at the close of business on September 30, 2025, representing

The Provident Bank Foundation Announces 2025 Empowerment Grant Recipients

The Provident Bank Foundation Announces 2025 Empowerment Grant Recipients GlobeNewswire August 07, 2025 WOODBRIDGE, NJ, Aug. 07, 2025 (GLOBE NEWSWIRE) — The Provident Bank Foundation (PBF) is proud to announce the recipients of its inaugural Empowerment Grant cycle. Amid the current challenging landscape for the nonprofit sector, PBF's Board of Directors has approved 41 multi-year

Anteriad Celebrates 25 Years of Growth for B2B Marketers

Anteriad Celebrates 25 Years of Growth for B2B Marketers B2B Marketing Clients Achieve Long-Lasting Success with Anteriad's Growth-Obsessed Approach GlobeNewswire August 07, 2025 Rye Brook, New York, Aug. 07, 2025 (GLOBE NEWSWIRE) — Anteriad, a global leader in data- and AI-driven, tech enabled B2B marketing solutions is celebrating 25 years since the company was originally

MBX Biosciences Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

MBX Biosciences Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights GlobeNewswire August 07, 2025 Topline results for the Phase 2 Avail(TM) trial of canvuparatide in hypoparathyroidism on track for Q3 2025 Imapextide (MBX 1416) Phase 2a trial initiation in patients with post-bariatric hypoglycemia anticipated in Q3 2025 MBX 4291 Phase 1 trial initiation

Rocket Doctor Strengthens Access to Care Across Ontario as ER Closures and Physician Shortages Rise

Rocket Doctor Strengthens Access to Care Across Ontario as ER Closures and Physician Shortages Rise GlobeNewswire August 07, 2025 2024 marked the worst year on record for ER closures in Ontario, with 1 in 5 hospitals experiencing unplanned shutdowns, especially in rural areas. Ontario's family physician workforce is aging, with 15% of patients attached to

REMINDER: Lassonde Industries Inc. Will Hold a Conference Call to Discuss Its Second Quarter 2025 Financial Results

REMINDER: Lassonde Industries Inc. Will Hold a Conference Call to Discuss Its Second Quarter 2025 Financial Results GlobeNewswire August 07, 2025 ROUGEMONT, Quebec, Aug. 07, 2025 (GLOBE NEWSWIRE) — Lassonde Industries Inc. (TSX: LAS.A) (“Lassonde” or the “Corporation”) is pleased to announce that it will host a conference call to discuss its financial results for

Apterra Infrastructure Capital Appoints David Law to Board of Directors

Apterra Infrastructure Capital Appoints David Law to Board of Directors Standard Chartered Managing Director Brings 30 Years of Global Financing Expertise to Apterra GlobeNewswire August 07, 2025 NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) — Apterra Infrastructure Capital LLC (“Apterra”), a leading infrastructure finance platform and affiliate of Apollo, today announced that David Law has

OptimumBank Holdings, Inc. Financial Performance for the Second Quarter of 2025

OptimumBank Holdings, Inc. Financial Performance for the Second Quarter of 2025 GlobeNewswire August 07, 2025 Fort Lauderdale, FL, Aug. 07, 2025 (GLOBE NEWSWIRE) — OptimumBank Holdings, Inc. (NYSE American: OPHC) (the “Company”) is a one-bank holding company and owns 100% of OptimumBank (the “Bank”). The Company is pleased to announce net earnings of $3.60 million,

Scroll to Top